Revenue Growth QoQ: Vigil Neuroscience Inc. (VIGL)

Corporate company logo of Vigil Neuro (VIGL)

How is the patient base maintained within the rare brain pathology treatment system supported by the FDA? Vigil Neuroscience (VIGL) develops drugs for neuroimmune regeneration, securing monopoly revenues through patents. However, the absence of current sales due to the research stage makes sustainability dependent on clinical outcomes. The quarterly change in sales volume confirms this, with the current level sitting around 0.00.

VIGL Vigil Neuroscience Quarterly Revenue Growth Rate (07/04/2022 - 08/16/2025)

VIGL (Vigil Neuro): analytical breakdowns and indicator data

- company stock exchange capitalization indicators:
- cash and cash flow metrics:
Fundamental company analysis:vigilneuro.com (VIGL)
Manufactured products of Vigil Neuroscience Inc.

This indicator measures the percentage change in sales volume between the current and previous quarters, allowing for an objective assessment of operating cash flow dynamics while filtering out market noise. By analyzing the QoQ revenue growth rate, an investor can benchmark the commercialization efficiency of Vigil Neuroscience (VIGL) against expectations for Phase 2 clinical trial results, where an increase in this metric would confirm market demand for the drugs.

Main competitors

BIIB - Revenue Growth QoQ|NBIX (Neurocrine Biosciences) - Sales Growth QoQ|RGC: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Axsome (AXSM)|Revenue Growth QoQ ACADIA Pharmaceuticals Inc|Quarterly Sales Growth Xenon Pharmaceuticals Inc (XENE)|Quarterly Revenue Growth VKTX|Quarterly Revenue Growth supernus.com (SUPN)|Revenue Growth QoQ Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Revenue Dynamics QoQ|Harmony Corp - Quarterly Revenue Growth|BHVN: Revenue Growth QoQ|AMLX: Quarterly Revenue Growth|TRVI: Sales Change QoQ|Revenue Growth QoQ Praxis Medicines|Quarterly Revenue Growth Rate Anavex AVXL|Revenue Growth QoQ CeriBell Corp (CBLL)|Sales Change QoQ PRTA|Quarterly Revenue Growth ALEC (Alector)|Annexon (ANNX) - Quarterly Revenue Growth Rate|OMER - Revenue Growth QoQ|NGNE (Neurogene) - Sales Growth QoQ|ACIU: Quarterly Revenue Growth|VYGR - Quarterly Sales Growth Rate|Revenue Growth QoQ Neumora Therapeutics, Inc.|Sales Growth QoQ SCLX (Scilex)|Quarterly Sales Growth TVGN (Tevogen Bio)|Quarterly Revenue Growth Alpha Cognition Inc (ACOG)|Quarterly Revenue Growth CGTX (cogrx.com)|Quarterly Sales Growth Rate Inhibikase Pharma (IKT)|SAVA: Quarterly Sales Growth|Quarterly Sales Growth Rate Assertio ASRT|COYA (coyatherapeutics.com) - Quarterly Sales Growth|Sales Growth QoQ VTGN|OVID (Ovid Therapeutics) - Quarterly Revenue Growth|Acumen Pharmaceuticals, Inc (ABOS) - Quarterly Sales Growth Rate|Revenue Growth QoQ CervoMed, Inc. (CRVO)|ATHE - Quarterly Revenue Growth Rate|Quarterly Revenue Growth CLNN (Clene Inc.)|Quarterly Sales Growth Rate PepGen Inc. (PEPG)|JUNS - Revenue Growth QoQ|Quarterly Revenue Growth Rate Relmada Corp|ANVS (Annovis Bio, Inc.) - Quarterly Sales Growth|Grace Tx (GRCE) - Quarterly Revenue Growth|Quarterly Sales Growth AIFF|Quarterly Revenue Growth anewmeds.com|Revenue Growth QoQ NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Quarterly Revenue Increase|MetaVia - Quarterly Sales Growth|NRXS: Sales Growth QoQ|Helius Medical Technologies, Inc. - Quarterly Revenue Growth|PASG: Revenue Growth QoQ|Neuphoria (NEUP) - Revenue Growth QoQ|Minerva Neurosciences - Quarterly Revenue Increase|ATHA (Athira Pharma, Inc.) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate addextherapeutics.com ADXN|Quarterly Sales Growth ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Quarterly Revenue Increase|Quarterly Revenue Growth PTIX (Protagenic)|Quarterly Revenue Growth pasitheaclinics.com KTTA|CRGT - Revenue Growth QoQ|Quarterly Revenue Increase ATXI (Avenue Therapeutics)|BCLI: Quarterly Revenue Growth|Cara Therapeutics - Quarterly Revenue Increase|Revenue Growth QoQ Chromocell Therapeutics Corporation|Quarterly Revenue Growth Eliem Therapeutics Inc.|Revenue Growth QoQ Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Quarterly Revenue Increase|Quarterly Revenue Growth MRNS (marinuspharma.com)|NKGN: Sales Growth QoQ|NRBO - Revenue Growth QoQ|SAGE - Quarterly Revenue Growth|Synaptogenix (SNPX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Trevena (TRVN)|Revenue Growth QoQ Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Sales Change QoQ